Tim Rühlig on how Europe's antibiotic dependence on China can give Beijing strategic leverage

Up to 90% of global antibiotic active ingredients are now produced ​outside Europe, mainly in China. "This is something that you should worry about," warned Tim Rühlig in Reuters, noting that China's market dominance gives it leverage to defend its strategic interests. 

Read his full analysis in the Commentary, 'The weak point: Why pharmaceutical security belongs at the heart of European defence'.